JAMAL FAWAZ: Open Payments
NPI 1003881335 · HAGERSTOWN, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$82,251 in 113 payments from 2 companies in 2025. Trend: 2023 $56,419 · 2024 $42,363 · 2025 $82,251
Speaker / faculty: $77,445Travel & lodging: $3,237Food & beverage: $1,562Education: $7
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 96 | $74,619 |
| Vanda Pharmaceuticals Inc. | 17 | $7,631 |
Products named: VRAYLAR, FANAPT.
Industry payments across MD — which companies pay providers there.
